A subclass of GABA(A)/benzodiazepine receptor exclusively localized in the limbic system

NeuroReport

Volumn 8, Issue 1, 1997, Pages 117-122

  Onoe, Hirotaka ^a,b   Tsukada, Hideo ^a,c   Nishiyama, Shingo ^c   Nakanishi, Satoshi ^d   Inoue, Osamu ^a,e   Långström, Bengt ^a,f   Watanabe, Yasuyoshi ^a,b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

^c CENTRAL RESEARCH LABORATORY   (Japan)

^d SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Benzodiazepine; Monkey; Positron emission tomography (PET); Ro15 4513; Aminobutyric acid A (GABA(A)) receptor

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; BENZODIAZEPINE RECEPTOR; FLUMAZENIL; RADIOLIGAND; RECEPTOR SUBTYPE; 4 AMINOBUTYRIC ACID A RECEPTOR; AZIDE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CARBON; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; LIMBIC SYSTEM; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; AFFINITY LABELING; ANIMAL; AUTORADIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HISTOLOGY; IMAGE PROCESSING; ISOTOPE LABELING; MACACA; METABOLISM;

AFFINITY LABELS; ANIMALS; AUTORADIOGRAPHY; AZIDES; BENZODIAZEPINES; CARBON RADIOISOTOPES; FEMALE; FLUMAZENIL; GABA MODULATORS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTOPE LABELING; LIMBIC SYSTEM; MACACA MULATTA; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030995895     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199612200-00024     Document Type: Article

References (24)

1. Haefely WE, Martin JR, Grayson RJ et al. Can J Psychiatry 38, 102-108 (1993).
2. Sieghart W. J Psychiatry Neurosci 19, 24-29 (1994).
3. Smith GB and Olsen RW. Trends Pharmacol Sci 16, 162-168 (1995).
4. Sieghart W. Trends Pharmacol Sci 13, 446-450 (1992).
5. Doble A and Martin IL. Trends Pharmacol Sci 13, 76-81 (1992)
6. Persohn E, Malherbe P and Richard JG. J Comp Neurol 326, 193-216 (1992).
7. Wisden W, Laurie DJ, Monyer H et al. J Neurosci. 12, 1040-1062 (1992).
8. Niehoff DL and Kuhar MJ. J Neurosci 3, 2091 (1983).
9. Kandel ER. Disorders of mood; depression, mania, and anxiety disorders. In: Kandel ER, Schwartz JH and Jessell TM, (eds). Principles of Neural Science, 3rd edn. Norwalk: Appleton and Lange, 1991: 869-883.
10. Pritchett DB and Seeburg PH. J Neurochem 54, 1802-1804 (1990).
11. Hadingham KL, Wingrove P, Le Bourdelles B et al. Mol Pharmacol 43, 970-975 (1993).
12. Mehta AK and Shank RP. Brain Res 704, 289-297 (1995).
13. Onoe H, Inoue O, Suzuki K et al. Brain Res 663, 191-198 (1994).
14. Brouillet E, Chavoix C, Khalili-Varasteh M et al. Mol Pharmacol 38, 445-451 (1990).
15. Munson PJ and Rodbard D. Anal Biochem 107, 220-239 (1980).
16. Snider R and Lee JC. A Stereotaxic Atlas of the Monkey Brain; Macaca mulatta Chicago: Chicago University Press, 1961.
17. Halldin C, Farde L, Litton JE et al. Psychopharmacology 108, 16-22 (1992).
18. Inoue O, Suhara T, Itoh T et al. Neurosci Lett 145, 133-136 (1992).
19. Dennis T, Dubois A, Benavides J et al. J Pharmacol Exp Ther 247, 309-322 (1988).
20. Papez JW. Arch Neurol Psychiatry 38, 725-743 (1937).
21. Weiskrantz L. J Comp Physiol Psychol 49, 381-391 (1956).
22. Nishijo H, Ono T and Nishino H. J Neurosci 8, 3570-3583 (1988).
23. Davis M. Annu Rev Neurosci 15, 353-375 (1992).
24. Shibata K, Kataoka Y, Gomita Y et al. Brain Res 234, 442-446 (1982).